The Working to Fight AMR coalition will work to raise awareness about antimicrobial resistance and advocate for policies that incentivize drugmakers to develop new antibiotics.
Coalition members include:
- Greg Frank, PhD, director of infectious disease policy at the Biotechnology Innovation Organization and director of Working to Fight AMR
- Aleks Engel, PhD, director of REPAIR Impact Fund at Novo Holdings
- Julie Louise Gerberding, MD, former CDC director and executive vice president and chief patient officer at Merck
- Eric Kimble, chief commercial officer at Entasis Therapeutics
- Werner Lanthaler, PhD, CEO at Evotec
- Evan Loh, MD, CEO at Paratek Pharmaceuticals and chairman of the Antimicrobials Working Group
- Kevin Outterson, co-director of the health law program and professor at Boston University School of Law
- Ruben Tommasi, PhD, chief scientific officer at Entasis Therapeutics
- Zachary Zimmerman, PhD, CEO at Forge Therapeutics
To learn more about the coalition, click here.
More articles on clinical leadership and infection control:
6 Boston hospital employees on leave amid patient abuse investigation
Northwell graduates 20 ER nurses from sexual assault nurse examiner program
49% of healthcare professionals feel equipped to achieve zero harm, survey finds
